(EIS) MSCI Israel - Overview
Etf: Technology, Financials, Consumer, Healthcare, Industrials
Dividends
| Dividend Yield | 1.57% |
| Yield on Cost 5y | 2.55% |
| Yield CAGR 5y | 18.16% |
| Payout Consistency | 82.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.5% |
| Relative Tail Risk | 1.02% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.69 |
| Alpha | 34.44 |
| Character TTM | |
|---|---|
| Beta | 0.765 |
| Beta Downside | 0.686 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.10% |
| CAGR/Max DD | 1.27 |
Description: EIS MSCI Israel December 31, 2025
The iShares MSCI Israel ETF (EIS) commits at least 80% of its net assets to the securities that comprise the MSCI Israel Index, or to assets that closely mirror their economic characteristics. The index is free-float-adjusted and market-cap weighted, spanning large-, mid- and small-cap Israeli equities, and the fund is classified as non-diversified under U.S. regulations.
Key data points to note: as of the latest filing, the top three holdings are Bank Hapoalim, Teva Pharmaceutical Industries, and Check Point Software, together representing roughly 30% of assets; sector weights are dominated by financials (~35%) and technology (~22%); and Israel’s GDP growth has averaged about 3% YoY over the past five years, supported by a robust R&D ecosystem that spends roughly 4.5% of GDP on innovation, a leading global rate.
For a deeper quantitative breakdown, you might explore the fund’s metrics on ValueRay.
What is the price of EIS shares?
Over the past week, the price has changed by +0.77%, over one month by +3.10%, over three months by +18.28% and over the past year by +48.14%.
Is EIS a buy, sell or hold?
What are the forecasts/targets for the EIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 143.8 | 19.9% |
EIS Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 765.3m USD (765.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 765.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 765.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.73% (E(765.3m)/V(765.3m) * Re(8.73%) + (debt-free company))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)